the associated risks, including melanoma (skin cancer) made clear
Many athletes struggle with bloating, poor digestion, meal skipping, dehydration, and constant GI distress during intense training blocks
Patients who were treated with liraglutide showed significantly lower PASI and fasting plasma glucose, whereas there was no significant difference in body mass index (BMI), DLQI, and hemoglobin A1C
The FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list - the regulatory mechanism that governs which bulk drug substances large-scale outsourcing facilities may use in compounding
Paediatricians should advise parents about the symptoms and signs of PIMS-TS so that timely medical consultation can be sought